A new AI tool developed by researchers at the University of Bristol is enhancing predictive capabilities for patients with prostate cancer, specifically identifying who would benefit from focal therapy. This technology leverages machine learning algorithms to analyze patient data, aiming to improve treatment outcomes and reduce unnecessary procedures.
Read more
Harnessing AI can significantly enhance the efficiency and effectiveness of clinical trials in the cancer industry, with companies like Tempus using machine learning to analyze large datasets for more personalized treatment options. By employing natural language processing and predictive analytics, organizations such as GRAIL are improving patient recruitment and monitoring, thereby accelerating drug development and optimizing outcomes for cancer patients.
Read more
Predictive Oncology, a company focused on advancing cancer care, utilizes artificial intelligence to enhance drug development and patient outcomes by analyzing tumor samples through its proprietary platform, SiiRNA. The firm's approach leverages machine learning and deep learning techniques to predict cancer responses to treatments, with significant advancements seen in personalized medicine and targeted therapies, exemplified by their collaboration with various medical institutions to refine treatment strategies.
Read more
Artificial intelligence is being utilized to analyze the 3D shapes of cancer cells to predict their response to various drugs, enhancing personalized treatment strategies. Researchers from the Massachusetts Institute of Technology and the National Cancer Institute have developed a machine learning model that accurately correlates cell morphology with drug sensitivity, demonstrating its potential to improve decision-making in cancer therapies.
Read moreAI fingerprint technology is being developed to advance cancer drug design, focusing on identifying unique biomolecular signatures associated with effective treatment responses. Companies like Iovance Biotherapeutics are utilizing machine learning and computational modeling to enhance the precision of cancer therapeutics, ultimately aiming to improve patient outcomes and streamline drug development processes.
Read more
Altis Labs has developed an AI model called iPro that analyzes medical scans for lung and colorectal cancer, which enhances clinical trial targeting and risk assessment for patients. This technology leverages machine learning to improve the precision of identifying patients eligible for clinical trials and highlights the growing role of AI in transforming cancer diagnostics and treatment strategies.
Read more
Lunit is collaborating with AstraZeneca to present research on using artificial intelligence for predicting EGFR mutations in patients with non-small cell lung cancer (NSCLC) at AACR 2025. The study highlights Lunit's advancements in machine learning applications aimed at improving cancer treatment personalization through predictive models.
Read moreAI-driven digital twins and Python simulations are transforming cancer care by creating virtual models that can predict patient responses to treatments. Companies like Tempus and IBM Watson Health are leveraging these technologies to enhance personalized treatment plans and improve outcomes for cancer patients.
Read more
AI is transforming bladder cancer treatment by personalizing patient care through advanced data analysis and predictive modeling, enabling medical professionals to tailor therapies based on individual patient profiles. Companies like Tempus leverage machine learning and natural language processing to streamline data collection and enhance treatment decisions, while tools like IBM Watson are being explored for their potential to analyze vast amounts of cancer research and clinical data, ultimately improving patient outcomes.
Read more
Artificial intelligence, specifically in the form of machine learning models like GPT and LLMs, is revolutionizing the cancer industry by improving early detection rates and treatment options. Companies like Paige, Tempus, and Freenome are leveraging AI and neural networks to develop advanced diagnostic tools and personalized therapies for cancer patients, ultimately benefiting consumers by increasing survival rates and improving quality of life.
Read more
Google has announced new healthcare tools and features, including the ability for users to receive advice from people with similar symptoms through online forums. The company is utilizing Artificial Intelligence and Machine Learning to provide personalized health information and improve the overall user experience, with examples such as Google Health's Cancer Industry Solutions and partnerships with cancer companies like Tempus and Foundation Medicine.
Read more
Artificial intelligence technologies, such as deep learning and natural language processing, are being used to advance colorectal cancer screening by companies like Freenome and Exact Sciences. These AI-powered tools are improving the accuracy and efficiency of cancer detection, ultimately benefiting consumers by providing earlier diagnosis and personalized treatment options.
Read more
Recent advances in AI technology like Generative Adversarial Networks and Neural Networks have shown promise in improving the accuracy of colon cancer detection, leading to potential breakthroughs in the cancer industry. Companies like Tempus and IBM Watson are leveraging machine learning and deep learning algorithms to analyze medical images and genetic data, enhancing the efficiency of diagnosing and treating cancer for better outcomes for patients.
Read more
The American Gastroenterological Association (AGA) has issued new recommendations on AI-assisted colonoscopy technology, emphasizing its potential to improve the accuracy of colon cancer detection and surveillance. Companies such as Medtronic and Cosmo Pharmaceuticals are incorporating AI technology into their colonoscopy devices to enhance diagnostics and patient outcomes in the cancer industry.
Read more
AI-powered mammograms are being used to detect hidden cardiovascular risks in women, offering early detection of heart disease. Companies such as Google Health and Northwestern University have conducted research showing that AI algorithms can analyze mammograms to predict a woman's risk of developing heart disease in the future. This innovative use of AI in the healthcare industry has the potential to revolutionize the way cardiovascular risks are identified and managed in cancer patients.
Read more
Researchers have developed a deep learning model called CancerTransformer that can predict cancer patient outcomes and potentially optimize treatment strategies using AI-driven approaches. This model has been applied to real-world cancer genomics data from The Cancer Genome Atlas (TCGA) to identify biomarkers and therapeutic targets in the pharmaceutical industry, showing promising results in advancing precision medicine for cancer patients.
Read more
A neural network called LLM has been developed by scientists at KIST for predicting the success of cancer treatment. This AI technology analyzes data from cancer patients to provide personalized treatment recommendations, with companies like IBM's Watson also using similar AI algorithms for cancer research.
Read more
GE Healthcare has launched an AI-powered ultrasound system called Invenia Automated Breast Ultrasound (ABUS) 2.0, which aims to improve early detection of breast cancer in women with dense breast tissue. This technology utilizes Artificial Intelligence to provide more accurate and efficient imaging, ultimately benefiting both cancer patients and healthcare providers by enabling earlier detection and treatment.
Read more
Insilico Medicine has raised $110 million to further their AI-driven drug discovery innovations, leveraging generative AI models like LLMs and GPT to develop new cancer therapies faster and more efficiently for companies like Juvenescence and OncoSenX. This funding will allow Insilico Medicine to continue making significant advancements in the cancer industry by utilizing cutting-edge artificial intelligence technologies such as deep learning and natural language processing in their research and product development.
Read more
The American Cancer Society (ACS) has partnered with Layer Health to improve data extraction using their LLM technology, leading to more efficient processing of cancer-related information for companies like Pfizer and Bayer. This collaboration leverages advanced AI techniques like NLP to streamline data analysis and contribute to advancements in cancer research and product development.
Read more
Vanderbilt researchers are using Artificial Intelligence to develop antibody therapies for various targets in the cancer industry. They are employing machine learning algorithms to design new cancer treatments, such as a recent study that used Generative AI models like GPT-3 to develop novel antibodies against tumor cells.
Read more
AI-powered healthcare diagnostics are transforming the medical industry, increasing accuracy and efficiency in cancer detection and treatment. Companies like PathAI and Paige are utilizing Machine Learning and Deep Learning algorithms to analyze pathology images, while Tempus is using data-driven AI technologies to personalize cancer treatments based on patient data.
Read moreNvidia is revolutionizing genomic research in the cancer industry by leveraging AI technologies such as deep learning and natural language processing. For example, their deep learning model Evo 2 has been successful in predicting drug responses for cancer patients, leading to more personalized and effective treatment options.
Read moreMayo Clinic Labs has partnered with nference to utilize artificial intelligence and machine learning to analyze cancer research data and develop new insights for cancer treatment. The collaboration between Mayo Clinic Labs and nference has led to the discovery of promising novel targets and biomarkers for cancer therapeutics, with specific examples including the use of deep learning algorithms to identify potential drug candidates for cancer treatment like Kras inhibitors.
Read morePharmaceutical companies like Merck and Pfizer are using Artificial Intelligence, Machine Learning, and Deep Learning to revolutionize drug discovery processes, leading to faster and more efficient development of cancer treatments. These technologies are helping companies analyze vast amounts of data, predict drug responses, and develop personalized therapies for cancer patients, ultimately transforming the cancer industry and benefiting consumers with more effective products.
Read more
Would you like us to add an industry? Let us know
Would you like us to add a health topic? Let us know
Would you like us to add a profession? Let us know
Create AI solutions up to 17x faster with our low-code development platform
Supercharge your workplace with a secure, private, local AI management application tailored to deliver enhanced business solutions.
Synchronize your workforce with an AI-driven management system that optimizes task delegation, and communication to empower frontline teams and boost productivity.
